Jackson Park Capital’s Kindred Biosciences, Inc. KIN Stock Holding History

Jackson Park Capital’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$293K	Sell	69,000 -8,000	-10%	-$38.7K	0.55%	35
2016 Q3	$383K	Hold	77,000	–	–	0.5%	39
2016 Q2	$273K	Hold	77,000	–	–	0.37%	39
2016 Q1	$266K	Hold	77,000	–	–	0.34%	38
2015 Q4	$262K	Buy	77,000 +20,000	+35%	+$92.8K	0.27%	28
2015 Q3	$296K	Hold	57,000	–	–	0.26%	32
2015 Q2	$389K	Hold	57,000	–	–	0.32%	32
2015 Q1	$407K	Hold	57,000	–	–	0.35%	32
2014 Q4	$425K	Buy	+57,000	New	+$483K	0.34%	35

Other funds holding KIN

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Jackson Park Capital's KIN Position: Q4 2016 in Review

Jackson Park Capital reduced its Kindred Biosciences, Inc. (KIN) stake by 10% in Q4 2016, selling an estimated $38.7K and leaving 69,000 shares worth $293K. The position accounts for 0.55% of the portfolio, ranked #35.

Jackson Park Capital first reported a position in KIN in Q4 2014 and has held it in 9 quarters since. The position peaked at $425K in Q4 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

Jackson Park Capital held 69,000 shares of Kindred Biosciences, Inc. worth $293K as of Q4 2016.
Jackson Park Capital sold 8,000 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $38.7K.
Kindred Biosciences, Inc. made up 0.55% of Jackson Park Capital's portfolio in Q4 2016, its #35 holding.
Jackson Park Capital first reported a position in Kindred Biosciences, Inc. in Q4 2014 and has held it in 9 quarters since.
Jackson Park Capital's Kindred Biosciences, Inc. position peaked at $425K in Q4 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on Jackson Park Capital's 13F filing for Q4 2016, filed 1 Feb 2017.